TickerFacts.

A business in context

ABT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001805099-26-000008

  2. 4 · Ownership change

    Report date 2026-09-01 · 0001644207-26-000012

  3. 4 · Ownership change

    Report date 2026-08-25 · 0001612571-26-000011

  4. 8-K · Current report

    Report date 2026-08-20 · 0001104659-26-099247 · Items 7.01,8.01,9.01

  5. 4 · Ownership change

    Report date 2026-08-11 · 0001867666-26-000013

  6. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001628280-26-050134

  7. 8-K · Current report

    Report date 2026-07-16 · 0001628280-26-048377 · Items 2.02,9.01

  8. 4 · Ownership change

    Report date 2026-06-30 · 0002102715-26-000006

  9. 4 · Ownership change

    Report date 2026-06-30 · 0001879701-26-000008

  10. 4 · Ownership change

    Report date 2026-06-30 · 0001867666-26-000009

  11. 4 · Ownership change

    Report date 2026-06-30 · 0001577544-26-000010

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001628280-26-028357

  13. 8-K · Current report

    Report date 2026-04-24 · 0001104659-26-049434 · Items 5.02,5.03,5.07,9.01

  14. 8-K · Current report

    Report date 2026-04-10 · 0001104659-26-044892 · Items 8.01,9.01

  15. 8-K · Current report

    Report date 2026-04-16 · 0001628280-26-025365 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-03-23 · 0001104659-26-033079 · Items 8.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-04-24 · 0001308179-26-000064

  18. 8-K · Current report

    Report date 2026-03-09 · 0001104659-26-025240 · Items 1.01,2.03,9.01

  19. 8-K · Current report

    Report date 2026-02-23 · 0001104659-26-020509 · Items 1.01,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001628280-26-010185

  21. 8-K · Current report

    Report date 2026-02-20 · 0001104659-26-018167 · Items 5.03,9.01

  22. 8-K · Current report

    Report date 2026-01-22 · 0001628280-26-002982 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-12-12 · 0001104659-25-120657 · Items 5.02,5.03,9.01

  24. 8-K · Current report

    Report date 2025-11-18 · 0001104659-25-114995 · Items 5.04,9.01

  25. 8-K · Current report

    Report date 2025-11-19 · 0001104659-25-114422 · Items 1.01,7.01,8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001628280-25-047131

  27. 8-K · Current report

    Report date 2025-10-15 · 0001628280-25-045049 · Items 2.02,9.01

  28. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001628280-25-036720

  29. 8-K · Current report

    Report date 2025-07-17 · 0001628280-25-035135 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-04-25 · 0001104659-25-043508 · Items 5.02

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001628280-25-021090

  32. 8-K · Current report

    Report date 2025-04-25 · 0001104659-25-040201 · Items 5.07

  33. 8-K · Current report

    Report date 2025-04-16 · 0001628280-25-017924 · Items 2.02,9.01

  34. DEF 14A · Proxy statement

    Report date 2025-04-25 · 0001308179-25-000134

  35. 10-K · Annual report

    Report date 2024-12-31 · 0001628280-25-007110

  36. 8-K · Current report

    Report date 2025-01-22 · 0001628280-25-002092 · Items 2.02,9.01

  37. 8-K · Current report

    Report date 2024-11-12 · 0001104659-24-119717 · Items 5.02

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001628280-24-044602

  39. 8-K · Current report

    Report date 2024-10-16 · 0001628280-24-042893 · Items 2.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001628280-24-033740

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 3 transaction rows3PSale: 0 transaction rows0SGrant / award: 20 transaction rows20AExercise / conversion: 0 transaction rows0MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

26 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-27
2026-06-29
Cushman Elizabeth C.F · Tax / exercise payment
Disposed
Common shares without par value560.094.12
2026-05-07
2026-06-18
Stratton John GP · Purchase
Acquired
Common shares without par value2000.086.82
2026-04-28
2026-04-29
Moreland Mary KI · Other (see filing)
Acquired
Common shares without par value5314.094.41
2026-04-27
2026-04-28
STARKS DANIEL JP · Purchase
Acquired
Common shares without par value10000.092.65
2026-04-24
2026-04-28
Ahuja NitaA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
Gonzalez Patricia PaolaA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
McDew Darren WA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
Babineaux-Fontenot ClaireA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
Kumbier MichelleA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
Roman Michael FA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
Blount Sally E.A · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
O'Grady MichaelA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
O'Grady MichaelA · Grant / award
Acquired
Option (right to buy)
Derivative security
5929.00.0
2026-04-24
2026-04-28
Stratton John GA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
Conroy Kevin TA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
McKinstry NancyA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
McKinstry NancyA · Grant / award
Acquired
Option (right to buy)
Derivative security
2305.00.0
2026-04-24
2026-04-28
STARKS DANIEL JA · Grant / award
Acquired
Common shares without par value2286.00.0
2026-04-24
2026-04-28
STARKS DANIEL JA · Grant / award
Acquired
Option (right to buy)
Derivative security
7105.00.0
2026-04-23
2026-04-27
Boudreau Philip PP · Purchase
Acquired
Common shares without par value2200.091.5
2026-04-23
2026-04-27
Boudreau Philip PI · Other (see filing)
Acquired
Common shares without par value8909.092.04
2026-03-31
2026-04-02
Ahuja NitaA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
102.0102.67
2026-03-31
2026-04-02
Gonzalez Patricia PaolaA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
321.0102.67
2026-03-31
2026-04-02
Roman Michael FA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
367.0102.67
2026-03-31
2026-04-02
Alpern Robert JA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
76.0102.67
2026-03-31
2026-04-02
Stratton John GA · Grant / award
Acquired
Stock Equivalent Units
Derivative security
382.0102.67

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000001800ABBOTT LABORATORIES
Abbott SpainAbbott (Canada)Abbott JapanAbbott (South Korea)Abbott (Germany)Abbott LaboratoriesAbbott Rapid Diagnostics Jena GmbHAbbott (Chile)

Showing 8 of 8 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
HQD377W2YR662HK5JX27
GLEIF legal name
ABBOTT LABORATORIES
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-09-02T18:36:07Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Abbott Labs · alias · wikidata
  • Abbott Laboratories, Inc. · alias · wikidata
  • Ross Laboratories · alias · wikidata
  • Abbott Pharmaceuticals · alias · wikidata
  • Abbott Nutrition · alias · wikidata
  • I-STAT · alias · wikidata
  • Abbott Molecular · alias · wikidata
  • Isomil · alias · wikidata
  • Abbot Laboratories · alias · wikidata
  • Abbott · alias · wikidata
  • Abbott Spain · subsidiary · wikidata
  • Abbott (Canada) · subsidiary · wikidata
  • Abbott Japan · subsidiary · wikidata
  • Abbott (Japan) · subsidiary · wikidata
  • Dainabot · subsidiary · wikidata
  • Abbott (South Korea) · subsidiary · wikidata
  • Abbott (Germany) · subsidiary · wikidata
  • Abbott Laboratories · subsidiary · wikidata
  • Abbott (United Kingdom) · subsidiary · wikidata
  • Abbott Rapid Diagnostics Jena GmbH · subsidiary · wikidata
  • Abbott (Chile) · subsidiary · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$41.95B$44.65B
2023-12-31$40.11B$43.95B
2022-12-31$43.65B$49.80B
2021-12-31$43.08B$53.07B
2020-12-31$34.61B$44.65B
2019-12-31$31.90B$41.67B
2018-12-31$30.58B$40.66B
2017-12-31$27.39B$37.31B

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗